Valens GroWorks Corp (CSE:VGW) (the “Company” or “Valens”) is pleased to announce wholly-owned subsidiary Valens Agritech Ltd. has successfully harvested its first premium Cannabis crop under its Health Canada Dealer’s License.

Valens’ state-of-the-art growing facility, high standards, and the experience of our Master Growers has produced a robust crop yield with THC content that exceeded expectations, coming in with 24% potential THC compared to an industry average 18.5% for the strain produced.


  • Valens is a company focused on the extraction of Cannabis into oil. Higher THC content produces a greater yield of finished oil products, providing an opportunity to enhance operating margins.
  • Valens has one of the highest extraction processing capacities in Canada for refined, proprietary extraction into 100% pure Cannabis oil. The ability to control our inputs with premium harvested product such as this initial crop is a key component to maximizing our production process going forward.
  • In April Valens AgriTech completed the installation of two additional Vitalis Q-90 CO2 extraction machines, significantly raising the amount of cannabis that can be processed.

Valens CEO, Tyler Robson commented: “I am very proud of the Valens cultivation team. Their experience, care and passion for their work really came through and has resulted in an exceptional product and standards in our facility. Our Master Growers believe they have the ability to continuously exceed industry averages. Our current growing and extraction facility has been renovated and is in the process of being Good Manufacturing Practices certified. Valens Farms, our new cultivation facility currently under way, will benefit greatly from our first harvest as we continually strive to improve in every way.”

About Valens GroWorks

Valens GroWorks Corp. is a vertically integrated provider of Canadian cannabis products which come from our proprietary extraction techniques, with three wholly-owned subsidiaries located in Kelowna, BC. Subsidiary Valens Agritech has initiated cannabis production, processing and sales under a Health Canada Dealers Licence, which includes a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network. Subsidiary Supra THC Services is a Health Canada licensed cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Medicine Analytics. Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for medical or (in future) adult usage purposes. Valens will be the first company to encompass the ‘whole plant’ extraction process which reduces costs and produces a premium extract. For more information, please visit http://valensgroworks.comhttp://www.valensagritech.com and http://www.suprathc.ca.

Notice regarding Forward Looking Statements

This news release contains certain “forward-looking statements” within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as “anticipates”, “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed”, “positioned” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Corporation is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

The CSE or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

Click here to connect with Valens GroWorks Corp (CSE:VGW) for an Investor Presentation.

Source: www.newswire.ca

Significant progress made as Numinus-sponsored PRIME study on psilocybin-assisted psychotherapy for opioid, stimulant and/or alcohol use disorders enters pre-implementation stage

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract research organization with expertise in conducting clinical trials across a broad range of diseases, are pleased to share that significant progress has been made in the single-arm, open-label compassionate access 1 trial of Psilocybin-Research Intervention with Motivational Enhancement (PRIME) for substance use disorders. Currently in the development stage, the PRIME study will assess the efficacy and safety of psilocybin-assisted motivational enhancement therapy.

Keep reading... Show less

Expanding offering of traditional and cannabinoid-infused beverages and natural products through four major sales channels to reach growing consumer base

Diversified health and wellness; beverage and natural products company, BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide an outlook on its strategic evolution into a diversified health & wellness beverage and natural products company.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant” or the “Company”) is pleased to announce the appointment of Gabriel Villablanca as its Vice President of Marketing. Villablanca previously held the position of Director of eCommerce and will assume duties as VP of Marketing immediately. In this role, he will be responsible for leading marketing strategy as Better Plant’s brands continue to expand.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/75790_e6d0c14f742d6a4c_001.jpg

Better Plant Appoints Gabriel Villablanca as Vice President of Marketing

Keep reading... Show less

Koios has engaged NewAge, a Denver-based distributor of beverages and snacks, to carry its KOIOS™ nootropic beverages and Fit Soda™ functional beverages throughout Colorado and potentially in other markets. Koios anticipates that NewAge’s in-depth knowledge of functional beverages, in addition to its significant footprint in Colorado can complement Koios’ existing presence in the state and potentially create new opportunities for the Company.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that it has entered into a distribution agreement with NewAge, Inc. (“NewAge”) (NASDAQ: NBEV), a major omnichannel wholesaler of beverages and snacks. Based in Denver Colorado, NewAge provides direct store delivery (“DSD”) service for beverage brands all across the state of Colorado, primarily in the Front Range region. Koios believes its engagement with NewAge can strengthen the Company’s existing presence in Colorado, which benefits from Koios’ prestige as a local business. NewAge will distribute all of Koios’ beverage products including KOIOS™ nootropic beverages and Fit Soda™ functional beverages (collectively, the “Koios Beverages”). In 2021 the Company announced several placements of Koios Beverages in local grocery chains in regions to include New England Utah Oregon Louisiana Massachusetts and California in addition to a placement of Fit Soda ™ in over 100 HEB supermarkets in Texas announced in November 2020. With approval for Koios Beverages to be sold through the NewAge distribution network, new placements could be finalized much more rapidly and enable the Company to further grow its base of more than 4,000 points of sale in the United States.

Keep reading... Show less

Company anticipates escalation in cultivation to have direct effect on revenue growth

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (OTC: TCNAF) (“TransCanna” or the “Company”) has increased its cultivation capacity by 300%, enabling it to effectively triple production of its most profitable and in-demand product: exotic indoor flower. With this increased cultivation capacity, Lyfted Farms – hailed in the industry for its premium genetics and seasoned team of master cultivators – can now meet consumer-driven demand in Northern California while expanding into the sizable Southern California home containing over 23,000,000 residents.

Keep reading... Show less